Timothy A. Yap, James L. Gulley, Manish R. Sharma, Patricia LoRusso, Chris N. Barnes, Martin Decaris, Jenny Carolina Amaya Amaya. "Cohort expansion of a phase I study of PLN-101095, a first-in-class dual α v β 8 /α v β 1 integrin inhibitor, in combination with pembrolizumab in patients with advanced solid tumors refractory to immune checkpoint inhibitors (ICI).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps2690